US body Clinical and Laboratory Standards Institute (CLSI) awards high susceptibility breakpoints to…
Currently, Zaynich is undergoing a multinational Phase 3 study, which is expected to be completed by FY 2025
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
E.Coli
Researchers develop compound to kill gram-positive and gram-negative antibiotic-resistant superbugs
Reportedly, doctors have not had a new treatment for gram-negative bacteria in the last 50 years, and no potential drugs have…